PINK:RAFA

Rafarma Pharmaceuticals Stock Predictions

Healthcare > Drug Manufacturers - Specialty & Generic

Buy RAFA

*Your capital is at risk

$0.0260

-0.0009 (-3.32%)

At Close: Jul 31, 2026

Currently predicting for Mon, 3 Aug 2026

RAFA Live board

Community Bull/Bear

Target Next close

Join the RAFA prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

RAFA Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For RAFA

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

RAFA Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT RAFARMA PHARMACEUTICALS, INC.

Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. It offers cephalosporin-based products, antibiotics of non-ß structure, and anti-cancer drugs in the form of injections, ampulla packaged products, child suspensions, tablets, and capsules. The company also provides drugs for accidental wounds, inflammatory eye diseases, and immunological ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
FOX $50.81	2.22%	Jul 27
UNFI $49.05	3.63%	Jul 27
BIIB $202.19	0.376%	Jul 24
TSCO $30.32	1.48%	Jul 23
S SW $43.71	5.17%	Jul 23

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by